Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes Body Care Children Complications Defeat Diabetes Foundation Drugs    » ACE Inhibitor    » Actos    » Alternative Medicine    » Aspirin    » Avandia    » Byetta    » Drugs    » Exenatide    » Glargine    » Glucophage    » Insulin    » Januvia    » Lantus    » Liraglutide    » Metformin    » Recall    » Research    » Rosiglitazone    » Self-Management    » Statins    » Sulfonylureas    » Victoza Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

Drugs

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

Pramlintide Curbs Fast Food Consumption and Binge Eating Posted: Friday, June 22, 2007

The synthetic form of a hormone previously found to produce a feeling of fullness when eating and reduce body weight, also may help curb binge eating and the desire to eat high-fat foods and sweets.

Drug Prevents Diabetes and Heart Disease Posted: Friday, June 22, 2007

An experimental drug prevented mice from developing diabetes and heart disease and might one day be used to stave off the diseases in humans, U.S. researchers said last week.

New Study Shows Chromium Improves Diabetes and Lipid Control Posted: Friday, June 22, 2007

Published results from a 447 subject, randomized, double-blind, placebo-controlled clinical study showed Diachrome, a patented combination of chromium picolinate and biotin, significantly improved glycemic control in patients with poorly controlled blood sugar levels who were being treated with oral anti-diabetic medication (OADs).

Slow Release Topiramate Helps Diabetics Lose Weight Posted: Friday, June 22, 2007

A controlled release formulation of topiramate is effective adjunctive therapy for weight loss in obese type 2 diabetics treated with diet and exercise alone or in combination with metformin, researchers report in the June issue of Diabetes Care.

New Study Shows No Increased Heart Risk With Avandia Posted: Thursday, June 14, 2007

Findings from an interim analysis of RECORD (Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of glycemia in Diabetes), shows further proof the safety of Avandia.

FDA Orders New Safety Labels for Rosiglitazone (Avandia) and Pioglitazone (Actos) Posted: Thursday, June 14, 2007

The FDA Commissioner Andrew C. von Eschenbach, M.D., told a congressional hearing that the FDA will beef up the cardiovascular warnings on the labels of both rosiglitazone (Avandia) and pioglitazone (Actos).

Once-Weekly Exenatide Formulation Improves Glycemic Control and Body Weight Posted: Thursday, June 14, 2007

There were no serious adverse events related to exenatide use, the report indicates, and none of the mild to moderate adverse events required discontinuation of exenatide LAR.

Study Tests Oral Insulin to Prevent Type 1 Diabetes Posted: Friday, June 08, 2007

University of Florida researchers have begun a clinical study of oral insulin to prevent or delay type 1 diabetes in people at risk for the disease.

Prescriber's Letter Clarifies Avandia Heart Attack Warning With Algorithm Posted: Friday, June 08, 2007

Analysts at Prescriber's Letter say that crunching the study's numbers reveals only part of the story. Since this report is a meta-analysis, it is merely a study of prior study results.

Resistance to Daily Aspirin Therapy Seen in Diabetics Posted: Friday, June 01, 2007

Diabetic patients exhibit a higher prevalence of aspirin resistance at a dosage of 81 mg/day than do nondiabetics with coronary artery disease.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.